The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Boyko A.N.

Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies

Belova A.N.

Privolzhsky Research Medical University

Rakhmanova E.M.

Privolzhsky Research Medical University

Sivertseva S.A.

Tyumen Regional Center for Multiple Sclerosis, Medical unit «Neftyanik»;
Ural State Medical University;
Kirov State Medical University

Questionnaires for arm function assessment in patients with multiple sclerosis

Authors:

Boyko A.N., Belova A.N., Rakhmanova E.M., Sivertseva S.A.

More about the authors

Read: 1571 times


To cite this article:

Boyko AN, Belova AN, Rakhmanova EM, Sivertseva SA. Questionnaires for arm function assessment in patients with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(6):36‑42. (In Russ.)
https://doi.org/10.17116/jnevro202412406136

Recommended articles:
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30
Epidemiology of multiple scle­rosis in the city of Novo­sibirsk. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):119-127
A clinical case of X-linked adre­noleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Arti­ficial inte­lligence capa­bilities in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):14-21
Inadvertent perioperative hypo­thermia in plastic surgery. Plastic Surgery and Aesthetic Medi­cine. 2025;(1):5-13
Key specific tools for asse­ssment of life quality of patients with psoriasis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):319-325

References:

  1. Feys P, Lamers I, Francis G, et al; Multiple Sclerosis Outcome Assessments Consortium. The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis. Mult Scler. 2017;23(5):711-720.  https://doi.org/10.1177/1352458517690824
  2. Grange E, Solaro C, Di Giovanni R, et al. The correlation between 9-HPT and patient-reported measures of upper limb function in multiple sclerosis: a systematic review and meta-analysis. J Neurol. 2023;270(9):4179-4191. https://doi.org/10.1007/s00415-023-11801-3
  3. Bertoni R, Lamers I, Chen CC, et al. Unilateral and bilateral upper limb dysfunction at body functions, activity and participation levels in people with multiple sclerosis. Mult Scler. 2015;21(12):1566-1574. https://doi.org/10.1177/1352458514567553
  4. Ertekin O, Kahraman T, Aras M, et al. Cross-cultural adaptation and psychometric properties of the Turkish version of the Manual Ability Measure-36 (MAM-36) in people with multiple sclerosis. Neurol Sci. 2021l;42(7):2927-2936. https://doi.org/10.1007/s10072-020-04927-z
  5. Kamm CP, Heldner MR, Vanbellingen T, et al. Limb apraxia in multiple sclerosis: prevalence and impact on manual dexterity and activities of daily living. Arch Phys Med Rehabil. 2012;93(6):1081-1085. https://doi.org/10.1016/j.apmr.2012.01.008
  6. Kister I, Bacon TE, Chamot E, et al. Natural history of multiple sclerosis symptoms. Int J MS Care. 2013;15(3):146-158.  https://doi.org/10.7224/1537-2073.2012-053
  7. Mokkink LB, Knol DL, van der Linden FH, et al. The Arm Function in Multiple Sclerosis Questionnaire (AMSQ): development and validation of a new tool using IRT methods. Disabil Rehabil. 2015;37(26):2445-2451. https://doi.org/10.3109/09638288.2015.1027005
  8. Molenaar PCG, Strijbis EMM, van Munster CEP, et al. Cross-sectional and longitudinal correlations between the Arm Function in Multiple Sclerosis Questionnaire (AMSQ) and other outcome measures in multiple sclerosis. Mult Scler Relat Disord. 2022;61:103725. https://doi.org/10.1016/j.msard.2022.103725.
  9. Inojosa H, Schriefer D, Ziemssen T. Clinical outcome measures in multiple sclerosis: A review. Autoimmun Rev. 2020;19(5):102512. https://doi.org/10.1016/j.autrev.2020.102512
  10. Kahraman T. Performance Measures for Upper Extremity Functions in Persons with Multiple Sclerosis. Noro Psikiyatr Ars. 2018;55(suppl 1):S41-S45.  https://doi.org/10.29399/npa.23317
  11. Churruca K, Pomare C, Ellis LA, et al. Patient-reported outcome measures (PROMs): A review of generic and condition-specific measures and a discussion of trends and issues. Health Expect. 2021;24(4):1015-1024. https://doi.org/10.1111/hex.13254
  12. Lamers I, Timmermans AA, Kerkhofs L, et al. Self-reported use of the upper limbs related to clinical tests in persons with multiple sclerosis. Disabil Rehabil. 2013;35(23):2016-2020. https://doi.org/10.3109/09638288.2013.771703
  13. Ramp M, Khan F, Misajon RA, et al. Rasch analysis of the Multiple Sclerosis Impact Scale MSIS-29. Health Qual Life Outcomes. 2009;7:58.  https://doi.org/10.1186/1477-7525-7-58
  14. Hobart J, Lamping D, Fitzpatrick R, et al. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain. 2001;124(5):962-973.  https://doi.org/10.1093/brain/124.5.962
  15. Gold SM, Heesen C, Schulz H, et al. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Mult Scler. 2001;7(2):119-130.  https://doi.org/10.1177/135245850100700208
  16. Rezaei S, Saberi A, Hatamian H, et al. Adaptation and Validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS) for Use in Iranian Patients. Acta Neurol Taiwan. 2022;31(1):24-35. 
  17. Sharrack B, Hughes RA. The Guy’s Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Multiple Sclerosis Journal. 1999;5(4):223-233.  https://doi.org/10.1177/135245859900500406
  18. Rossier P, Wade DT. The Guy’s Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity. Clin Rehabil. 2002;16(1):75-95.  https://doi.org/10.1191/0269215502cr447oa
  19. Fraser C, McGurl J. Psychometric testing of the Americanized version of the Guy’s Neurological Disability Scale. J Neurosci Nurs. 2007;39(1):13-19.  https://doi.org/10.1097/01376517-200702000-00004
  20. Mokkink LB, Knol DL, Uitdehaag BM. Factor structure of Guy’s Neurological Disability Scale in a sample of Dutch patients with multiple sclerosis. Mult Scler. 2011;17(12):1498-1503. https://doi.org/10.1177/1352458511413098
  21. Lamers I, Kelchtermans S, Baert I, Feys P. Upper limb assessment in multiple sclerosis: a systematic review of outcome measures and their psychometric properties. Arch Phys Med Rehabil. 2014;95(6):1184-1200. https://doi.org/10.1016/j.apmr.2014.023
  22. Chen CC, Granger CV, Peimer CA, et al. Manual Ability Measure (MAM-16): A preliminary report on a new patient-centred and task-oriented outcome measure of hand function. Journal of Hand Surgery. 2005;30(2):207-216.  https://doi.org/10.1016/j.jhsb.2004.12.005
  23. Chen CC, Kasven N, Karpatkin HI, et al. Hand strength and perceived manual ability among patients with multiple sclerosis. Archives of Physical Medicine and Rehabilitation. 2007;88(6):794-797.  https://doi.org/10.1016/j.apmr.2007.03.010
  24. Prada V, Tacchino A, Podda J, et al. MAM-36 and ABILHAND as outcome measures of multiple sclerosis hand disability: an observational study. Eur J Phys Rehabil Med. 2021;57(4):520-526.  https://doi.org/10.23736/S1973-9087.20.06446-1
  25. Penta M, Thonnard JL, Tesio L. ABILHAND: a Rasch-built measure of manual ability. Arch Phys Med Rehabil. 1998;79(9):1038-1042. https://doi.org/10.1016/s0003-9993(98)90167-8
  26. Cleanthous S, Strzok S, Pompilus F, et al. Addressing the targeting range of the ABILHAND-56 in relapsing — remitting multiple sclerosis: A mixed methods psychometric study. Multiple Sclerosis Journal — Experimental, Translational and Clinical. 2018;4(2):2055217318776990. https://doi.org/10.1177/2055217318776990
  27. Barrett L, Cano S, Zajicek J, et al. Lending a hand: can DASH items help ABILHAND improve manual ability measurement in multiple sclerosis? Mult Scler. 2015;21(5):612-621.  https://doi.org/10.1177/1352458514549396
  28. Barrett LE, Cano SJ, Zajicek JP, et al. Can the ABILHAND handle manual ability in MS? Mult Scler. 2013;19(6):806-815.  https://doi.org/10.1177/1352458512462919
  29. Hudak PL, Amadio PC, Bombardier C. Development of an upper corrected. The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996;29(6):602-608.  https://doi.org/10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L
  30. Cano SJ, Barrett LE, Zajicek JP, et al. Beyond the reach of traditional analyses: using Rasch to evaluate the DASH in people with multiple sclerosis. Mult Scler. 2011;17(2):214-222.  https://doi.org/10.1177/1352458510385269
  31. Taub E, Miller NE, Novack TA, et al. Technique to improve chronic motor deficit after stroke. Arch Phys Med Rehabil. 1993;74:347-354. 
  32. Mark VW, Taub E, Uswatte G, et al. Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 1: Effects on Real-World Function. Neurorehabil Neural Repair. 2018;32(3):223-232.  https://doi.org/10.1177/1545968318761050
  33. Feys P, Coninx K, Kerkhofs L, et al. Robot-supported upper limb training in a virtual learning environment: a pilot randomized controlled trial in persons with MS. J Neuroeng Rehabil. 2015;23:12:60.  https://doi.org/10.1186/s12984-015-0043-3
  34. Barghi A, Allendorfer JB, Taub E, et al. Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 2: Effect on White Matter Integrity. Neurorehabil Neural Repair. 2018;32(3):233-241.  https://doi.org/10.1177/1545968317753073
  35. Van de Winckel A, Gauthier L. A Revised Motor Activity Log Following Rasch Validation (Rasch-Based MAL-18) and Consensus Methods in Chronic Stroke and Multiple Sclerosis. Neurorehabil Neural Repair. 2019;33(10):787-791.  https://doi.org/10.1177/1545968319868717
  36. Luijten MA, Eekhout I, D’Hooghe M, et al. Development of the Arm Function in Multiple Sclerosis Questionnaire-Short Form (AMSQ-SF): A static 10-item version. Mult Scler. 2018;24(14):1892-1901. https://doi.org/10.1177/1352458518808197
  37. Solaro C, Di Giovanni R, Grange E, et al. Italian translation and psychometric validation of the Manual Ability Measure-36 (MAM-36) and its correlation with an objective measure of upper limb function in patients with multiple sclerosis. Neurol Sci. 2020;41(6):1539-1546. https://doi.org/10.1007/s10072-020-04263-2
  38. Chen CC, Bode RK. Psychometric validation of the ManualAbility Measure-36 (MAM-36) in patients with neurologic and musculoskeletal disorders. Arch Phys Med Rehabil. 2010;91(3):414-420.  https://doi.org/10.1016/j.apmr.2009.11.012
  39. Solaro C, Di Giovanni R, Grange E, et al. Correlation between patient-reported manual ability and three objective measures of upper limb function in people with multiple sclerosis. Eur J Neurol. 2023;30(1):172-178.  https://doi.org/10.1111/ene.15560
  40. Iagdzhian GV, Abraamian DO, Grigorian BE, et al. The Russian version of the DASH questionnaire: a tool for investigating the outcomes of treatment of upper limb lesions. Annals of plastic, reconstructive and aesthetic surgery. Annaly Plasticheskoi, Rekonstruktivnoi i Esteticheskoi Khirurgii. 2005;1:52-58. (In Russ.).
  41. Kalkers NF, Galan I, Kerbrat A, et al. Differential item functioning of the Arm function in Multiple Sclerosis Questionnaire (AMSQ) by language, a study in six countries. Mult Scler. 2021;27(1):90-96.  https://doi.org/10.1177/1352458519895450
  42. Lamers I, Kerkhofs L, Raats J, et al. Perceived and actual arm performance in multiple sclerosis: relationship with clinical tests according to hand dominance. Mult Scler. 2013;19(10):1341134-8.  https://doi.org/10.1177/1352458513475832
  43. van Leeuwen LM, Mokkink LB, Kamm CP, et al. Measurement properties of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ): a study based on Classical Test Theory. Disabil Rehabil. 2017;39(20):2097-2104. https://doi.org/10.1080/09638288.2016.1213898
  44. van Munster CE, Kaya L, Obura M, et al. Minimal clinically important difference of improvement on the Arm Function in Multiple Sclerosis Questionnaire (AMSQ). Mult Scler. 2020;26(4):505-508.  https://doi.org/10.1177/1352458518823489
  45. Steinheimer S, Wendel M, Vanbellingen T, et al. The Arm Function in Multiple Sclerosis Questionnaire was successfully translated to German. J Hand Ther. 2018;31(1):137-140.e1.  https://doi.org/10.1016/j.jht.2017.09.010
  46. Tacchino A, Ponzio M, Pedullà L, et al. Italian validation of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ). Neurol Sci. 2020;41(11):3273-3281. https://doi.org/10.1007/s10072-020-04363-z
  47. Reeve BB, Hays RD, Bjorner JB, et al; PROMIS Cooperative Group. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care. 2007;45(5 suppl 1):S22-31.  https://doi.org/10.1097/01.mlr.0000250483.85507.04
  48. Walker CM. What’s the DIF? Why differential item functioning analyses are an important part of instrument development and validation. J Psychoeduc Assess. 2011;29(4):364-376.  https://doi.org/10.1177/0734282911406666

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.